Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States

Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States

We evaluated the vaccine effectiveness (VE) of two doses of recombinant zoster vaccine (RZV) against herpes zoster (HZ) and postherpetic neuralgia (PHN) in Chinese adults at Kaiser Permanente Southern California (KPSC). Chinese KPSC members were identified based on self-reported ethnicity or self-re...

Full description

Saved in:
Bibliographic Details
Main Authors: Ana Florea, Lina Sy, Lei Qian, Bradley Ackerson, Yi Luo, Jun Wu, Yanjun Cheng, Jennifer Ku, Leticia Vega Daily, Harpreet Takhar, Jeannie Song, Elizabeth Chmielewski-Yee, O’Mareen Spence, Harry Seifert, Driss Oraichi, Hung Fu Tseng
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Herpes zoster
recombinant zoster vaccine
shingles
vaccine
vaccine effectiveness
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2024.2327145
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items